Order Article Reprints

Bulygin KV, Beeraka NM, Saitgareeva AR, Nikolenko VN, Gareev I, Beylerli O, Akhmadeeva LR, Mikhaleva LM, Torres Solis LF, Solís Herrera A, et al. Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status. International Journal of Molecular Sciences. 2020; 21(18):6728. https://doi.org/10.3390/ijms21186728

Bulygin, Kirill V., Narasimha M. Beeraka, Aigul R. Saitgareeva, Vladimir N. Nikolenko, Ilgiz Gareev, Ozal Beylerli, Leila R. Akhmadeeva, Liudmila M. Mikhaleva, Luis Fernando Torres Solis, Arturo Solís Herrera, and et al. 2020. "Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status" International Journal of Molecular Sciences 21, no. 18: 6728. https://doi.org/10.3390/ijms21186728

Bulygin, K. V., Beeraka, N. M., Saitgareeva, A. R., Nikolenko, V. N., Gareev, I., Beylerli, O., Akhmadeeva, L. R., Mikhaleva, L. M., Torres Solis, L. F., Solís Herrera, A., Avila-Rodriguez, M. F., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020). Can miRNAs Be Considered as Diagnostic and Therapeutic Molecules in Ischemic Stroke Pathogenesis?—Current Status. International Journal of Molecular Sciences, 21(18), 6728. https://doi.org/10.3390/ijms21186728